121 related articles for article (PubMed ID: 16269926)
1. Cancer procoagulant in patients with adenocarcinomas.
Kaźmierczak M; Lewandowski K; Wojtukiewicz MZ; Turowiecka Z; Kołacz E; Lojko A; Skrzydlewska E; Zawilska K; Komarnicki M
Blood Coagul Fibrinolysis; 2005 Nov; 16(8):543-7. PubMed ID: 16269926
[TBL] [Abstract][Full Text] [Related]
2. [Cancer procoagulant activity in cases of esophageal, stomach and colorectal cancer considering progression degree and histological type of cancer].
Kozuszko B; Skrzydlewski Z; Sulkowska M; Snarska J; Kozłowski M; Skrzydlewska E; Zalewski B
Pol Merkur Lekarski; 2001 Sep; 11(63):218-20. PubMed ID: 11761814
[TBL] [Abstract][Full Text] [Related]
3. Procoagulant factors in patients with cancer.
Molnar S; Guglielmone H; Lavarda M; Rizzi ML; Jarchum G
Hematology; 2007 Dec; 12(6):555-9. PubMed ID: 17852460
[TBL] [Abstract][Full Text] [Related]
4. Activation of blood coagulation and the activity of cancer procoagulant (EC 3.4.22.26) in breast cancer patients.
Mielicki WP; Tenderenda M; Rutkowski P; Chojnowski K
Cancer Lett; 1999 Nov; 146(1):61-6. PubMed ID: 10656610
[TBL] [Abstract][Full Text] [Related]
5. Causes of venous thrombosis in fifty Chinese patients.
Ho CH; Chau WK; Hsu HC; Gau JP; Yu TJ
Am J Hematol; 2000 Feb; 63(2):74-8. PubMed ID: 10629572
[TBL] [Abstract][Full Text] [Related]
6. Application of cancer procoagulant as an early detection tumor marker.
Kozwich DL; Kramer LC; Mielicki WP; Fotopoulos SS; Gordon SG
Cancer; 1994 Aug; 74(4):1367-76. PubMed ID: 8055461
[TBL] [Abstract][Full Text] [Related]
7. [Cancer procoagulant activity in serum and neoplastic tissue in cases of cervical and uterine carcinoma].
Szajda SD; Jóźwik M; Jóźwik M; Zalewska B; Panek G; Sulkowski S; Skrzydlewski Z
Ginekol Pol; 2004 Sep; 75(9):705-12. PubMed ID: 15600294
[TBL] [Abstract][Full Text] [Related]
8. Increased activity of procoagulant factors in patients with small cell lung cancer.
Pedersen S; Kristensen AF; Falkmer U; Christiansen G; Kristensen SR
PLoS One; 2021; 16(7):e0253613. PubMed ID: 34288927
[TBL] [Abstract][Full Text] [Related]
9. Assessment of coagulation disorders and cancer procoagulant activity in patients with myelodysplastic syndromes.
Chojnowski K; Treliński J; Wawrzyniak E; Sobolewska M; Mielicki W
Neoplasma; 2002; 49(3):155-8. PubMed ID: 12098000
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of examination of some tumor markers in diagnostics of liver cancer.
Snarska J; Szajda SD; Puchalski Z; Szmitkowski M; Chabielska E; Kaminski F; Zwierz P; Zwierz K
Hepatogastroenterology; 2006; 53(68):271-4. PubMed ID: 16608038
[TBL] [Abstract][Full Text] [Related]
11. Analysis of serum cancer procoagulant activity and its possible use as a tumor marker.
Gordon SG; Benson B
Thromb Res; 1989 Nov; 56(3):431-40. PubMed ID: 2617480
[TBL] [Abstract][Full Text] [Related]
12. The activity of cancer procoagulant in cases of uterine leiomyomas.
Jozwik M; Szajda SD; Skrzydlewski Z; Jozwik M; Sulkowski S
Eur J Gynaecol Oncol; 2005; 26(4):407-10. PubMed ID: 16122189
[TBL] [Abstract][Full Text] [Related]
13. Procoagulant activity in patients with isolated severe head trauma.
Scherer RU; Spangenberg P
Crit Care Med; 1998 Jan; 26(1):149-56. PubMed ID: 9428558
[TBL] [Abstract][Full Text] [Related]
14. Cancer procoagulant as a marker in monitoring the therapy in cases of oesophageal, stomach and colorectal cancer.
Kozuszko B; Skrzydlewska E; Snarska J; Kozłowski M; Zalewski B; Skrzydlewski Z
Folia Histochem Cytobiol; 2001; 39 Suppl 2():104-5. PubMed ID: 11820560
[TBL] [Abstract][Full Text] [Related]
15. [Cancer procoagulant and cathepsin D activity in blood serum in patients with bladder cancer].
Szajda SD; Darewicz B; Kudelski J; Chlabicz M; Domel T; Chabielska E; Skrzydlewski Z
Pol Merkur Lekarski; 2005 Jun; 18(108):651-3. PubMed ID: 16124376
[TBL] [Abstract][Full Text] [Related]
16. [Usefulness of detecting cancer procoagulant activity and thyrotropic hormone concentration in the differentiation of tumor-like changes in the thyroid].
Snarska J; Szajda SD; Knaś M; Mroczko B; Borzym-Kluczyk M; Kamiński F; Zwierz P; Zwierz K
Wiad Lek; 2006; 59(5-6):332-5. PubMed ID: 17017477
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel diagnostic biomarkers for deep venous thrombosis.
Memon AA; Sundquist K; PirouziFard M; Elf JL; Strandberg K; Svensson PJ; Sundquist J; Zöller B
Br J Haematol; 2018 May; 181(3):378-385. PubMed ID: 29672822
[TBL] [Abstract][Full Text] [Related]
18. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis.
Zhang D; Hao J; Yang N
J Gastroenterol Hepatol; 2010 Jan; 25(1):116-21. PubMed ID: 19686413
[TBL] [Abstract][Full Text] [Related]
19. Activity of cancer procoagulant (CP) in serum of patients with cancer of lung, breast, oesophagus and colorectum.
Rucińska M; Furman M; Skrzydlewski Z; Zaremba E
Acta Biochim Pol; 1997; 44(1):109-12. PubMed ID: 9241361
[TBL] [Abstract][Full Text] [Related]
20. [Incidence of deep venous thrombosis (DVT) in patients undergoing thoracotomy and changes of hemostasis].
Yuan XZ; Wu XM; Chen M; Yuan JY; Zhang SS
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 36(5):529-32. PubMed ID: 15489937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
